3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
5
Neoplasms
3
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Posterior Fossa Ependymal Tumor
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms by Site
1
Metabolic Diseases
1
Insulin Resistance
1
Infertility
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Drug-drug Interaction,SHR3680
1
Diabetes Mellitus, Type 2
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Breast Diseases
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Cyclophosphamide
10
fludarabine
7
pomalidomide
5
pembrolizumab
5
Dexamethasone
5
daratumumab
4
obinutuzumab
3
glofitamab
3
fludarabine phosphate
3
abemaciclib
3
Rituximab
3
Melphalan
3
Immunotherapy, Adoptive
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
pirtobrutinib
2
palbociclib
2
cemiplimab
2
blinatumomab
2
Temozolomide
2
Sirolimus
2
Oxaliplatin
2
Nivolumab
2
Mesna
2
Letrozole
2
Injections
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Metformin
×
30 days
×
Clear all
No trials found.